TOCILIZUMAB THERAPY IN CHILDREN WITH POLYARTHICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS

被引：0
|
作者：
Alexeeva, E. [1 ,2 ]
Denisova, R. [1 ]
Valieva, S. [1 ]
Bzarova, T. [1 ]
Isayeva, K. [1 ]
Sleptsova, T. [1 ]
Chistyakova, E. [1 ]
Chomahidze, A. [1 ]
Lomakina, O. [1 ]
Soloshenko, M. [1 ]
Fetisova, A. [1 ]
Kashchenko, E. [1 ]
机构：
[1] Sci Ctr Childrens Hlth, Rheumatol, Moscow, Russia
[2] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4871
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0268
引用
收藏
页码：765 / 765
页数：1
相关论文
共 50 条
  • [21] DYNAMICS OF GROWTH IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH TOCILIZUMAB
    Seraya, V.
    Zholobova, E.
    Vitebskaya, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1205 - 1206
  • [22] IDENTIFICATION OF OPTIMAL SUBCUTANEOUS (SC) DOSES OF TOCILIZUMAB IN CHILDREN WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS (PCJIA)
    De Benedetti, F.
    Ruperto, N.
    Lovell, D.
    Ramanan, A. V.
    Cuttica, R.
    Weiss, J. E.
    Henrickson, M.
    Schmeling, H.
    Anton, J.
    Minden, K.
    Hsu, J.
    Bharucha, K.
    Wimalasundera, S.
    Kadva, A. K.
    Upmanyu, R.
    Mallalieu, N. L.
    Martini, A.
    Brunner, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 396 - 396
  • [23] Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. DATA from Russian Register of Sjia
    Alexeeva, Ekaterina
    Valieva, Saniya
    Denisova, Rina
    Bzarova, Tatyana
    Isayeva, Kseniya
    Sleptsova, Tatyana
    Mitenko, Elena
    Chistyakova, Evgeniya
    Fetisova, Anna
    Lomakina, Olga
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1002 - S1002
  • [24] Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
    Herlin, Troels
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (06) : 517 - 525
  • [25] Safety of tocilizumab in the treatment of juvenile idiopathic arthritis
    Machado, Sandra Helena
    Xavier, Ricardo Machado
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 493 - 500
  • [26] Guidance on using tocilizumab for juvenile idiopathic arthritis
    Yokota, Shumpei
    Imagawa, Tomoyuki
    Takei, Syuji
    Murata, Takuji
    Tomiita, Minako
    Itoh, Yasuhiko
    Fujikawa, Satoshi
    Mori, Masaaki
    [J]. MODERN RHEUMATOLOGY, 2011, 21 (06) : 563 - 571
  • [27] Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
    Murakami, Miho
    Tomiita, Minako
    Nishimoto, Norihiro
    [J]. OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2012, 4 : 71 - 79
  • [28] PHARMACOECONOMIC EVALUATION OF TREATMENT WITH TOCILIZUMAB IN RUSSIAN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
    Ryazhenov, V. V.
    Gorokhova, S. G.
    Emchenko, I., V
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A380 - A380
  • [29] Identification of Optimal Subcutaneous Doses of Tocilizumab in Children with Systemic Juvenile Idiopathic Arthritis
    Brunner, Hermine I.
    Ruperto, Nicola
    Lovell, Daniel J.
    Horneff, Gerd
    Gamir-Gamir, Maria Luz
    Hufnagel, Markus
    Hsu, Joy
    Bao, Min
    Douglass, Wendy
    Mallalieu, Navita L.
    Wells, Chris
    Mala, Christopher M.
    De Benedetti, Fabrizio
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
    Yokota, S
    Miyamae, T
    Imagawa, T
    Katakura, S
    Kurosawa, R
    Mori, M
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 28 (03) : 231 - 237
12345